SCHEMBL7678740

SCHEMBL7678740

CCOCC1=NN=C(c2cccnc2)[N]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.40
CYP3A4 P08684 5/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP19A1 P11511 2/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
CYP2C9 P11712 4/20 0.39
CYP2C19 P33261 4/20 0.39
CYP2D6 P10635 3/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
CYP2E1 P05181 3/20 0.36
CYP2B6 P20813 3/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673942 0.86 CYP2A6 (0.44) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7682696 0.86 CYP3A4 (0.40) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7673098 0.83 KMT2A (0.43) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7676187 0.83 CYP2A6 (0.47) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7683444 0.82 CYP2A6 (0.37) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL7681288 0.79 CHRNB2 (0.41) CYP2A6CYP3A4ALDH1A1CYP1A2MKNK1
SCHEMBL7680376 0.78 KDM4E (0.47) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7673235 0.78 CHRM2 (0.40) ALDH1A1CYP11B2MKNK1MKNK2MEN1
SCHEMBL7676360 0.77 CYP2A6 (0.40) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7674967 0.76 MKNK1 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed